Kao J - Search Results

1

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM, Witt ME, Haraf DJ. Salama JK, et al. Among authors: kao j. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):382-91. doi: 10.1016/j.ijrobp.2005.07.005. Epub 2005 Oct 5. Int J Radiat Oncol Biol Phys. 2006. PMID: 16213104

2

Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome.

Stock RG, Stone NN, Lo YC, Malhado N, Kao J, DeWyngaert JK. Stock RG, et al. Among authors: kao j. Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):899-906. doi: 10.1016/s0360-3016(00)00707-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 11020588

3

Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.

Kao J, Garofalo MC, Milano MT, Chmura SJ, Citron JR, Haraf DJ. Kao J, et al. Cancer Treat Rev. 2003 Feb;29(1):21-30. doi: 10.1016/s0305-7372(02)00096-8. Cancer Treat Rev. 2003. PMID: 12633577 Review.

4

Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?

Salama JK, Heimann R, Lin F, Mehta N, Chmura SJ, Singh R, Kao J. Salama JK, et al. Among authors: kao j. Cancer. 2005 Feb 15;103(4):664-71. doi: 10.1002/cncr.20830. Cancer. 2005. PMID: 15641038 Free article.

5

Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis.

Jani AB, Kao J, Heimann R, Hellman S. Jani AB, et al. Among authors: kao j. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):687-94. doi: 10.1016/j.ijrobp.2004.09.066. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708246

6

Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.

Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, Masters GA, Fleming GF, Heimann R. Kao J, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1045-53. doi: 10.1016/j.ijrobp.2004.07.714. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752883 Clinical Trial.

7

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

Milano MT, Vokes EE, Salama JK, Stenson KM, Kao J, Witt ME, Mittal BB, Argiris A, Weichselbaum RR, Haraf DJ. Milano MT, et al. Among authors: kao j. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1096-106. doi: 10.1016/j.ijrobp.2004.08.029. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752889 Clinical Trial.

8

Cellular response to DNA damage.

Kao J, Rosenstein BS, Peters S, Milano MT, Kron SJ. Kao J, et al. Ann N Y Acad Sci. 2005 Dec;1066:243-58. doi: 10.1196/annals.1363.012. Ann N Y Acad Sci. 2005. PMID: 16533929 Review.

9

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.

Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ. Milano MT, et al. Among authors: kao j. Int J Oncol. 2006 May;28(5):1141-51. Int J Oncol. 2006. PMID: 16596230 Clinical Trial.

10

gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy.

Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR, Kron SJ. Kao J, et al. Curr Cancer Drug Targets. 2006 May;6(3):197-205. doi: 10.2174/156800906776842957. Curr Cancer Drug Targets. 2006. PMID: 16712457 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,806 results

Search Page

Filters